6BGH

Solution NMR structure of Brd3 ET domain bound to Brg1 peptide

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-13C HSQC	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 800
2	3D 1H-13C NOESY	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 800
3	3D 1H-15N NOESY	300 uM [U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 800
4	3D 13C/15N (F2/F1) Filtered, 1H-1H NOESY	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 800
5	2D 13C/15N (F2/F1) Filtered, 1H-1H NOESY	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600
6	2D 13C/15N (F2/F1) Filtered, 1H-1H TOCSY	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600
7	3D HCCH-TOCSY	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 800
8	3D HCCH-COSY	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 800
9	2D 1H-1H TOCSY	300 uM Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 800
10	2D 1H-1H NOESY	300 uM Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600
11	3D HNCO	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600
12	2D 1H-15N HSQC	300 uM [U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600
13	3D HN(CA)CO	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600
14	3D H(CC)(CO)HN	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600
15	3D HNCA	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600
16	3D CBCA(CO)NH	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600
17	3D HNCACB	300 uM [U-13C; U-15N] Brd3_ET, 600 uM Brg1, 0.02 % Roche Complete Protease Inhibitor, 166 uM DSS	90% H2O/10% D2O	50 NaCl mM	7	1 atm	298	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600
2	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	1000
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger A. T. et.al.